Fulgent Genetics, Inc. (FLGT) financial statements (2022 and earlier)

Company profile

Business Address 4978 SANTA ANITA AVENUE, SUITE 205
TEMPLE CITY, CA 91780
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16529928312621
Cash and cash equivalents1658712768
Short-term investments 21216242013
Receivables1391847644
Other current assets23402321
Other undisclosed current assets286     
Total current assets:61252437403326
Noncurrent Assets
Finance lease, right-of-use asset2  
Operating lease, right-of-use asset713
Property, plant and equipment62406676
Long-term investments and receivables4851334381726
Long-term investments4851334381726
Intangible assets, net (including goodwill)87     
Goodwill51     
Intangible assets, net (excluding goodwill)36     
Other noncurrent assets1130000
Deferred tax assets, net 0 
Other undisclosed noncurrent assets13    0
Total noncurrent assets:66717752142432
TOTAL ASSETS:1,27970089545758
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39883333
Accounts payable20262123
Accrued liabilities1881110
Taxes payable1530  0
Deferred revenue15270
Debt6 0   
Business combination, contingent consideration, liability10     
Other liabilities1     
Other undisclosed current liabilities3515    
Total current liabilities:1051304333
Noncurrent Liabilities
Long-term debt and lease obligation 12   
Operating lease, liability 12
Liabilities, other than long-term debt70 000
Deferred tax liabilities, net  0
Other liabilities70 000
Other undisclosed noncurrent liabilities10    
Total noncurrent liabilities:812000
Total liabilities:1131316334
Stockholders' equity
Stockholders' equity attributable to parent1,15956983515454
Common stock000000
Additional paid in capital502418146114112110
Accumulated other comprehensive income (loss)(1)00(0)(0)(0)
Retained earnings (accumulated deficit)658151(63)(63)(58)(55)
Stockholders' equity attributable to noncontrolling interest7     
Total stockholders' equity:1,16656983515454
TOTAL LIABILITIES AND EQUITY:1,27970089545758

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues99342233211918
Cost of revenue(216)(90)(14)(11)(9)(7)
Gross profit:77733218111012
Operating expenses(101)(42)(19)(16)(14)(11)
Operating income (loss):676290(0)(5)(3)1
Interest and debt expense(0)(0)    
Other undisclosed income from continuing operations before equity method investments, income taxes 2100 
Income (loss) from continuing operations before equity method investments, income taxes:6762920(5)(3)1
Loss from equity method investments (0)(1)(1)(1) 
Other undisclosed income (loss) from continuing operations before income taxes1    (5)
Income (loss) from continuing operations before income taxes:677291(0)(6)(4)(4)
Income tax expense (benefit)(175)(73)(0)(0)1(1)
Income (loss) from continuing operations:503219(0)(6)(3)(5)
Income from discontinued operations     0
Income (loss) before gain (loss) on sale of properties:503219(0)(6)(3)(5)
Other undisclosed net income (loss)4(4)    
Net income (loss):506214(0)(6)(3)(5)
Net income attributable to noncontrolling interest1     
Net income (loss) attributable to parent:507214(0)(6)(3)(5)
Other undisclosed net loss available to common stockholders, basic     (8)
Net income (loss) available to common stockholders, diluted:507214(0)(6)(3)(14)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):506214(0)(6)(3)(5)
Other comprehensive income (loss)(1)0000(0)
Comprehensive income (loss):505215(0)(6)(2)(5)
Comprehensive income, net of tax, attributable to noncontrolling interest1     
Comprehensive income (loss), net of tax, attributable to parent:506215(0)(6)(2)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: